 |
|
|
| |
SVR IS THE STRONGEST PREDICTOR OF OCCURRENCE AND
RECURRENCE OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC
PATIENTS AFTER TREATMENT WITH DIRECT ACTING ANTIVIRALS:
A PROSPECTIVE MULTICENTER ITALIAN STUDY.
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Session-Clinical impact of HCV cure
Ana Lleo, Andrea Aglitti, Alessia Ciancio, Vito Di Marco, Alessio Aghemo, Massimo Colombo, Pietro Lampertco, Maurizia R. Brunetto, Massimo Zuin, Pietro Andreone, Erica Villa, Giulia Troshina, Vincenza Calvaruso, Elisabetta Degasperi, Barbara Coco, Alessia M. Giorgini, Fabio Conti, Alfredo Di Leo, Luca Marzi, Vincenzo Boccaccio, Simona Bollani, Patrick Maisonneuve, Maria Rendina, Marcello Persico, Savino Bruno
|
| |
|
|
|
|
|
